BDNF and CREB1 genetic variants interact to affect antidepressant treatment outcomes in geriatric depression
The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
AIM: Brain-derived neurotrophic factor (BDNF) is associated with antidepressant response on the cellular level, in animal models, and in clinical studies. A common variant in the BDNF gene results in a substitution of a methionine (Met) for a valine at the amino acid position 66. Previous studies reported that the Met variant results in enhanced response to antidepressant medications. These findings may be at odds with studies indicating that on a cellular level the Met variant impairs the secretion of BDNF. MATERIALS AND METHODS: We examined the effects of BDNF single nucleotide polymorphisms (SNPs) in response to the antidepressants paroxetine and mirtazapine in a sample of 246 geriatric patients with major depression, treated in a double-blind, randomized, 8-week clinical trial. We also examined the effects of genetic variation at the BDNF-related loci neurotrophic tyrosine kinase receptor 2, cyclic AMP responsive element binding protein 1 (CREB1), and CREB binding protein. A total of 53 SNPs were genotyped. RESULTS: BDNF genetic variation had a significant effect on the efficacy of paroxetine, with patients carrying the Met allele showing impaired response. SNPs at the CREB1 locus, which encodes a transcription factor important in BDNF signaling, also predicted response to paroxetine. Furthermore, we found a significant gene-gene interaction between BDNF and CREB1 that affected response to paroxetine. Because BDNF has been associated with cognitive function, we tested the effects of BDNF SNPs on change in a wide variety of cognitive tests over the 8-week trial, but there were no significant effects of genotype on cognition. CONCLUSION: These results provide new evidence for the importance of the BDNF pathway in antidepressant response in geriatric patients. The negative effect of the Met66 allele on antidepressant outcomes is consistent with basic science findings indicating a negative effect of this variant on BDNF activity in the brain. Further, the effect of BDNF genetic variation on antidepressant treatment is modified by variation in the gene encoding the downstream effector CREB1.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another study of individuals with LLD found that the Met allele predicted poorer response to paroxetine, and that this effect was moderated by the cyclic AMP responsive element binding protein 1 (CREB1)207.”
From Psychobiological factors of resilience and depression in late life (2019) · cites this paper as [207]
In the citing paper
“Another study of individuals with LLD found that the Met allele predicted poorer response to paroxetine, and that this effect was moderated by the cyclic AMP responsive element binding protein 1 (CREB1)207.”
From Psychobiological factors of resilience and depression in late life (2019) · cites this paper as [207]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Development of a Rating Scale for Primary Depressive Illness
HAMILTON, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
A second generation human haplotype map of over 3.1 million SNPs
The International HapMap Consortium (2007) · Nature · doi:10.1038/nature06258 · Cited by 4,438
Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
Nibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109
Purification of a new neurotrophic factor from mammalian brain.
Barde, Y. A., Edgar, D., & Thoenen, H. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01207.x · Cited by 1,822
Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03251.2002 · Cited by 1,654
Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior
Chen, Z.-Y., Jing, D., Bath, K. G., Ieraci, A., Khan, T., Siao, C.-J., Herrera, D. G., Toth, M., Yang, C., McEwen, B. S., et al. (2006) · Science · doi:10.1126/science.1129663 · Cited by 1,340
Hariri, A. R., Goldberg, T. E., Mattay, V. S., Kolachana, B. S., Callicott, J. H., Egan, M. F., & Weinberger, D. R. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-17-06690.2003 · Cited by 1,045
Brunoni, A. R., Lopes, M., & Fregni, F. (2008) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009309 · Cited by 972
Pencea, V., Bingaman, K. D., Wiegand, S. J., & Luskin, M. B. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-17-06706.2001 · Cited by 927
Antidepressant-like effect of brain-derived neurotrophic factor (BDNF)
Siuciak, J. A., Lewis, D. R., Wiegand, S. J., & Lindsay, R. M. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00169-4 · Cited by 841
A Review of the Pharmacological and Clinical Profile of Mirtazapine
Anttila, S. A. K., & Leinonen, E. V. J. (2001) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2001.tb00198.x · Cited by 795
Sairanen, M., Lucas, G., Ernfors, P., Castrén, M., & Castrén, E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3741-04.2005 · Cited by 763
Pruunsild, P., Kazantseva, A., Aid, T., Palm, K., & Timmusk, T. (2007) · Genomics · doi:10.1016/j.ygeno.2007.05.004 · Cited by 699
Modarresi, F., Faghihi, M. A., Lopez-Toledano, M. A., Fatemi, R. P., Magistri, M., Brothers, S. P., van der Brug, M. P., & Wahlestedt, C. (2012) · Nature Biotechnology · doi:10.1038/nbt.2158 · Cited by 668
Brain‐derived neurotrophic factor and the development of structural neuronal connectivity
Cohen‐Cory, S., Kidane, A. H., Shirkey, N. J., & Marshak, S. (2010) · Developmental Neurobiology · doi:10.1002/dneu.20774 · Cited by 589
Bergami, M., Rimondini, R., Santi, S., Blum, R., Götz, M., & Canossa, M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803702105 · Cited by 415
Exercise, Antidepressant Medications, and Enhanced Brain Derived Neurotrophic Factor Expression
Russo-Neustadt, A. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00059-7 · Cited by 411
Peripheral BDNF Produces Antidepressant-Like Effects in Cellular and Behavioral Models
Schmidt, H. D., & Duman, R. S. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.114 · Cited by 403
Genes and the parsing of cognitive processes
Goldberg, T. E., & Weinberger, D. R. (2004) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2004.05.011 · Cited by 356
Chen, A. C.-H., Shirayama, Y., Shin, K.-H., Neve, R. L., & Duman, R. S. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01114-8 · Cited by 314
Pharmacogenetics of Antidepressant Medication Intolerance
Murphy, G. M., Kremer, C., Rodrigues, H. E., & Schatzberg, A. F. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.10.1830 · Cited by 283
Self-citationYu, H., Wang, D.-D., Wang, Y., Liu, T., Lee, F. S., & Chen, Z.-Y. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5048-11.2012 · Cited by 275
Caccamo, A., Maldonado, M. A., Bokov, A. F., Majumder, S., & Oddo, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012851108 · Cited by 249
The response of chick sensory neurons to brain-derived neurotrophic factor
Davies, A., Thoenen, H., & Barde, Y. (1986) · The Journal of Neuroscience · doi:10.1523/jneurosci.06-07-01897.1986 · Cited by 247
Double-Blind, Randomized Comparison of Mirtazapine and Paroxetine in Elderly Depressed Patients
Schatzberg, A. F., Kremer, C., Rodrigues, H. E., & Murphy, G. M. (2002) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200209000-00007 · Cited by 215
Self-citationTesting association between disease and multiple SNPs in a candidate gene
Gauderman, W. J., Murcray, C., Gilliland, F., & Conti, D. V. (2007) · Genetic Epidemiology · doi:10.1002/gepi.20219 · Cited by 202
Neural Circuitry of Anxiety: Evidence from Structural and Functional Neuroimaging Studies
Cannistraro, P. A., MD, Rauch, A. S. L., & MD (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4161 · Cited by 199
Dong, C., Wong, M.-L., & Licinio, J. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.92 · Cited by 182
Choi, M.-J., Kang, R.-H., Lim, S.-W., Oh, K.-S., & Lee, M.-S. (2006) · Brain Research · doi:10.1016/j.brainres.2006.08.012 · Cited by 180
Licinio, J., Dong, C., & Wong, M.-L. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.38 · Cited by 176
The CREB1-BDNF-NTRK2 Pathway in Depression: Multiple Gene-Cognition-Environment Interactions
Juhasz, G., Dunham, J. S., McKie, S., Thomas, E., Downey, D., Chase, D., Lloyd-Williams, K., Toth, Z. G., Platt, H., Mekli, K., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.11.019 · Cited by 159
Perlis, R. H., Purcell, S., Fava, M., Fagerness, J., Rush, A. J., Trivedi, M. H., & Smoller, J. W. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.6.689 · Cited by 148
Double-Blind, Randomized Comparison of Mirtazapine and Paroxetine in Elderly Depressed Patients
Schatzberg, A. F. (2002) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.10.5.541 · Cited by 146
Self-citationChronic antidepressant administration alleviates frontal and hippocampal BDNF deficits in CUMS rat
Zhang, Y., Gu, F., Chen, J., & Dong, W. (2010) · Brain Research · doi:10.1016/j.brainres.2010.09.095 · Cited by 135
Chen, M. J., & Russo‐Neustadt, A. A. (2009) · Hippocampus · doi:10.1002/hipo.20579 · Cited by 129
Impact of the BDNF Val66Met Polymorphism on Cognition: Implications for Behavioral Genetics
Dincheva, I., Glatt, C. E., & Lee, F. S. (2012) · The Neuroscientist · doi:10.1177/1073858411431646 · Cited by 127
BDNF Val66met polymorphism, white matter abnormalities and remission of geriatric depression
Alexopoulos, G. S., Glatt, C. E., Hoptman, M. J., Kanellopoulos, D., Murphy, C. F., Kelly, R. E., Morimoto, S. S., Lim, K. O., & Gunning, F. M. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.02.115 · Cited by 97
Zhang, J., Rowe, W. L., Clark, A. G., & Buetow, K. H. (2003) · The American Journal of Human Genetics · doi:10.1086/379154 · Cited by 97
BDNF Gene: Functional Val66Met Polymorphism in Mood Disorders and Schizophrenia
Rybakowski, J. K. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.11.1589 · Cited by 92
Goldberg, T. E., Iudicello, J. E., Russo, C., Elvevåg, B., Straub, R. E., Egan, M. F., & Weinberger, D. R. (2007) · Biological Psychology · doi:10.1016/j.biopsycho.2007.08.009 · Cited by 89
Ballard, D. H., Cho, J., & Zhao, H. (2010) · Genetic Epidemiology · doi:10.1002/gepi.20448 · Cited by 74
Wilkie, M. J. V., Smith, D., Reid, I. C., Day, R. K., Matthews, K., Roland Wolf, C., Blackwood, D., & Smith, G. (2007) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32801a3be6 · Cited by 74
Kocabas, N. A., Antonijevic, I., Faghel, C., Forray, C., Kasper, S., Lecrubier, Y., Linotte, S., Massat, I., Mendlewicz, J., Noro, M., et al. (2011) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32833d18f8 · Cited by 74
A population‐based association study of candidate genes for depression and sleep disturbance
Utge, S., Soronen, P., Partonen, T., Loukola, A., Kronholm, E., Pirkola, S., Nyman, E., Porkka‐Heiskanen, T., & Paunio, T. (2010) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31002 · Cited by 62
Lin, E., Hong, C.-J., Hwang, J.-P., Liou, Y.-J., Yang, C.-H., Cheng, D., & Tsai, S.-J. (2009) · Rejuvenation Research · doi:10.1089/rej.2009.0871 · Cited by 59
Kang, R., Chang, H., Wong, M., Choi, M., Park, J., Lee, H., Jung, I., Joe, S., Kim, L., Kim, S., et al. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109105457 · Cited by 55
Marker selection for genetic case–control association studies
Pettersson, F. H., Anderson, C. A., Clarke, G. M., Barrett, J. C., Cardon, L. R., Morris, A. P., & Zondervan, K. T. (2009) · Nature Protocols · doi:10.1038/nprot.2009.38 · Cited by 54
Chi, M. H., Chang, H. H., Lee, S.-Y., Lee, I. H., Gean, P. W., Yang, Y. K., Lu, R., & Chen, P. S. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.07.006 · Cited by 54
Serretti, A., Chiesa, A., Calati, R., Massat, I., Linotte, S., Kasper, S. F., Lecrubier, Y., Antonijevic, I. A., Forray, C., Snyder, L., et al. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.06.025 · Cited by 53
BDNF Val66Met genotype and 6-month remission rates in late-life depression
Taylor, W. D., McQuoid, D. R., Ashley-Koch, A., MacFall, J. R., Bridgers, J., Krishnan, R. R., & Steffens, D. C. (2011) · The Pharmacogenomics Journal · doi:10.1038/tpj.2010.12 · Cited by 50
Effects of BDNF Polymorphisms on Antidepressant Action
Tsai, S.-J., Hong, C.-J., & Liou, Y.-J. (2010) · Psychiatry Investigation · doi:10.4306/pi.2010.7.4.236 · Cited by 49
Murphy, G. M., Kremer, C. M. E., Rodrigues, H. E., & Schatzberg, A. F. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00174-4 · Cited by 47
Self-citationMolecular differentiation of schizoaffective disorder from schizophrenia using BDNF haplotypes
Lencz, T., Lipsky, R. H., DeRosse, P., Burdick, K. E., Kane, J. M., & Malhotra, A. K. (2009) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.108.050401 · Cited by 46
Cited by
Amare, A. T., Schubert, K. O., Klingler-Hoffmann, M., Cohen-Woods, S., & Baune, B. T. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.261 · Cited by 345
Psychobiological factors of resilience and depression in late life
Laird, K. T., Krause, B., Funes, C., & Lavretsky, H. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0424-7 · Cited by 229
Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network
Bush, W., Crosslin, D., Owusu‐Obeng, A., Wallace, J., Almoguera, B., Basford, M., Bielinski, S., Carrell, D., Connolly, J., Crawford, D., et al. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.350 · Cited by 182
Epigenetic alterations in depression and antidepressant treatment
Menke, A., & Binder, E. B. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.3/amenke · Cited by 161
Predictors of treatment outcome in depression in later life: A systematic review and meta-analysis
Tunvirachaisakul, C., Gould, R. L., Coulson, M., Ward, E. V., Reynolds, G., Gathercole, R. L., Grocott, H., Supasitthumrong, T., Tunvirachaisakul, A., Kimona, K., et al. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.10.008 · Cited by 128
Metadata
- Authors
- Murphy, G. M., Sarginson, J. E., Ryan, H. S., O’Hara, R., Schatzberg, A. F., & Lazzeroni, L. C.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Murphy, Greer M.
- Venue
- Pharmacogenetics and Genomics
- Published
- 2013-06
- Volume
- 23
- Issue
- 6
- Pages
- 301-313
- ISSN
- 1744-6872 (ISSN-L)
- OpenAlex
- W2056261919
- Cited by
- 50
- References
- 56
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 6 · 2019: 3 · 2018: 7 · 2017: 7 · 2016: 5 · 2015: 5 · 2014: 7 · 2013: 2
- FWCI
- 4.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pharmacogenetics and Genomics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (R01MH073914, MH-47573, R01MH050604, MH073914-04S1, MH073914, MH50604, R01MH086135, R01MH047573)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- brain-derived neurotrophic factor, CREB1, geriatric depression, major depressive disorder, antidepressant response, paroxetine, mirtazapine, gene-gene interaction, single nucleotide polymorphisms, CREB-binding protein, cognitive function, pharmacogenetics
- MeSH terms
- Aged, Alleles, Antidepressive Agents, Depression, Female, Gene Frequency, Haplotypes, Humans, Male, Models, Genetic, Linkage Disequilibrium, Likelihood Functions, Treatment Outcome, Cyclic AMP Response Element-Binding Protein, Brain-Derived Neurotrophic Factor, Polymorphism, Single Nucleotide, Principal Component Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.